VIDEO: Adding ixazomib to len-dex boosts progression-free survival in multiple myelomaApril 27, 2016Leukemia, Myelodysplasia, Transplantation
New single-tube assay detects one CLL cell in 1 million leukocytesApril 27, 2016Leukemia, Myelodysplasia, Transplantation
CML: T3151 plus additional mutations predicts poor response to ponatinibApril 22, 2016Leukemia, Myelodysplasia, Transplantation
Daratumumab well tolerated, effective in heavily treated multiple myelomaApril 22, 2016Leukemia, Myelodysplasia, Transplantation
Donor EBV status affects recipient graft-vs-host disease riskApril 18, 2016Leukemia, Myelodysplasia, Transplantation
Prelabor cesarean delivery linked to increased risk of childhood ALLApril 14, 2016Leukemia, Myelodysplasia, Transplantation
In newly diagnosed CLL, mutation tests are advisedApril 13, 2016Leukemia, Myelodysplasia, Transplantation
Rigosertib falls short for high-risk myelodysplastic syndromes after failure on azacitidine or decitabineApril 13, 2016Leukemia, Myelodysplasia, Transplantation
Rigosertib falls short for high-risk myelodysplastic syndromes after failure on azacitidine or decitabineApril 13, 2016Leukemia, Myelodysplasia, Transplantation
FDA approves venetoclax for CLL with 17p deletionApril 11, 2016Leukemia, Myelodysplasia, Transplantation
In myelodysplastic syndrome, improved tool for predicting death after HCTApril 11, 2016Leukemia, Myelodysplasia, Transplantation
Cyclophosphamide nets low rate of chronic GVHD after mobilized blood cell transplantationApril 2, 2016Leukemia, Myelodysplasia, Transplantation
Drug for conditioning AML patients for transplant gets orphan drug designationMarch 31, 2016Leukemia, Myelodysplasia, Transplantation
New drug approved for hepatic veno-occlusive diseaseMarch 31, 2016Leukemia, Myelodysplasia, Transplantation
